Amedisys, Inc. (AMED) DCF Valuation

AMEDISYS, Inc. (AMED) Valoración de DCF

US | Healthcare | Medical - Care Facilities | NASDAQ
Amedisys, Inc. (AMED) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Amedisys, Inc. (AMED) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero valor de Amedisys, Inc. (amed) con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo los cambios afectan la valoración de Amedisys, Inc. (AMED), todo dentro de una plantilla de Excel conveniente.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 2,071.5 2,214.1 2,223.2 2,236.4 2,348.3 2,424.0 2,502.1 2,582.8 2,666.0 2,752.0
Revenue Growth, % 0 6.88 0.41041 0.59297 5.01 3.22 3.22 3.22 3.22 3.22
EBITDA 250.7 320.7 207.4 216.9 73.4 236.3 243.9 251.8 259.9 268.3
EBITDA, % 12.1 14.48 9.33 9.7 3.13 9.75 9.75 9.75 9.75 9.75
Depreciation 28.8 30.9 24.9 23.8 18.0 27.8 28.7 29.7 30.6 31.6
Depreciation, % 1.39 1.4 1.12 1.07 0.76638 1.15 1.15 1.15 1.15 1.15
EBIT 221.9 289.8 182.5 193.1 55.5 208.5 215.2 222.1 229.3 236.7
EBIT, % 10.71 13.09 8.21 8.63 2.36 8.6 8.6 8.6 8.6 8.6
Total Cash 81.8 42.7 40.5 126.5 303.2 127.3 131.5 135.7 140.1 144.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 255.1 275.0 296.8 313.4 296.1
Account Receivables, % 12.32 12.42 13.35 14.01 12.61
Inventories 11.8 13.4 25.2 .0 .0 11.2 11.6 11.9 12.3 12.7
Inventories, % 0.56799 0.60661 1.13 0 0 0.46181 0.46181 0.46181 0.46181 0.46181
Accounts Payable 42.7 38.2 43.7 28.2 40.0 42.3 43.6 45.0 46.5 48.0
Accounts Payable, % 2.06 1.73 1.97 1.26 1.7 1.74 1.74 1.74 1.74 1.74
Capital Expenditure -5.3 -6.7 -7.2 -12.7 -6.6 -8.4 -8.7 -9.0 -9.2 -9.5
Capital Expenditure, % -0.2574 -0.30355 -0.32453 -0.56846 -0.27892 -0.34657 -0.34657 -0.34657 -0.34657 -0.34657
Tax Rate, % 49.86 49.86 49.86 49.86 49.86 49.86 49.86 49.86 49.86 49.86
EBITAT 193.2 216.2 135.1 -47.5 27.8 119.2 123.0 127.0 131.1 135.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.5 214.4 124.7 -43.2 68.3 112.1 134.0 138.3 142.7 147.3
WACC, % 7.25 7.14 7.14 6.49 6.93 6.99 6.99 6.99 6.99 6.99
PV UFCF
SUM PV UFCF 548.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 150
Terminal Value 3,011
Present Terminal Value 2,148
Enterprise Value 2,696
Net Debt 157
Equity Value 2,540
Diluted Shares Outstanding, MM 33
Equity Value Per Share 76.84

What You Will Receive

  • Pre-Filled Financial Model: Amedisys, Inc.'s (AMED) actual data enables accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other crucial drivers.
  • Real-Time Calculations: Automatic updates provide immediate results as you adjust inputs.
  • Professional-Grade Template: A polished Excel file crafted for top-tier valuation.
  • Flexible and Reusable: Designed for adaptability, allowing repeated application for in-depth forecasts.

Key Features

  • Comprehensive DCF Calculator: Provides detailed unlevered and levered DCF valuation models tailored for Amedisys, Inc. (AMED).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to Amedisys, Inc. (AMED).
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Amedisys, Inc. (AMED) projections.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Amedisys, Inc. (AMED).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for streamlined analysis of Amedisys, Inc. (AMED).

How It Works

  • Download: Obtain the pre-configured Excel file containing Amedisys, Inc.'s (AMED) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make changes.
  • Test Scenarios: Generate various forecasts and evaluate results side by side effortlessly.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose This Calculator for Amedisys, Inc. (AMED)?

  • Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
  • Accurate Data: Amedisys’s historical and projected financials are preloaded for precision.
  • Forecast Scenarios: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Amedisys, Inc. (AMED) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Amedisys, Inc. (AMED).
  • Consultants: Deliver professional valuation insights on Amedisys, Inc. (AMED) to clients quickly and accurately.
  • Business Owners: Understand how healthcare companies like Amedisys, Inc. (AMED) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Amedisys, Inc. (AMED).

What the Template Contains

  • Preloaded AMED Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.